regadenoson has been researched along with metoprolol in 2 studies
| Studies (regadenoson) | Trials (regadenoson) | Recent Studies (post-2010) (regadenoson) | Studies (metoprolol) | Trials (metoprolol) | Recent Studies (post-2010) (metoprolol) |
|---|---|---|---|---|---|
| 321 | 53 | 264 | 5,821 | 1,743 | 1,304 |
| Protein | Taxonomy | regadenoson (IC50) | metoprolol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 2.573 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.176 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 4.87 | |
| Cytochrome P450 2J2 | Homo sapiens (human) | 4.87 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Belardinelli, L; Hintze, TH; Ochoa, M; Shryock, JC; Xu, X; Zhang, S; Zhao, G | 1 |
1 review(s) available for regadenoson and metoprolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for regadenoson and metoprolol
| Article | Year |
|---|---|
Selective action of metoprolol to attenuate regadenoson-induced tachycardia in conscious dogs.
Topics: Animals; Anti-Arrhythmia Agents; Dogs; Heart Rate; Male; Metoprolol; Purines; Pyrazoles; Tachycardia; Treatment Outcome; Vasodilator Agents | 2012 |